AGENDA
2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics
Topic 1: Large Language Models in...
Introduction
Addiction medicine is becoming more of an issue as addiction-related problems continue to plague people all over the globe, resulting in serious health consequences. Addiction has become increasingly prevalent in recent years...
Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...
Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs.
Methods: Foll...
The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...
Panel Presented at Indonesia 2025 on the 18th of September 2025
Moderator: Kristiana Siste
Narendra Narotama: Quality Matters: Transforming the Future of Drug Use Disorder Treatment
Annete Dale-Perera: Supporting...
Com a globalização e o aumento do transporte e da comunicação, o transtorno por uso de substâncias (SUD) tornou-se um desafio global significativo. O Oriente Médio serve tanto como fonte quanto como centro de trânsito para muitas...
Background:
In 2023, the prevalence of drug abuse in Indonesia among the population aged 15–64 years reached 1.73%, equivalent to 3.33 million people. This problem has prompted The National Narcotics Board (BNN) as a government agency which...
Background
Stigma related to drug use is a well-documented barrier to engaging and remaining on medication for opioid use disorder (MOUD), yet little is known about how stigma operates across multiple social and institutional settings in...
Background
Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking...
Substance abuse in Indonesia is on the rise each year. Rehabilitation centers play a crucial role in helping individuals recover from addiction and improve their quality of life (recovery, productivity, and social functioning). However...
On June 26, 2025, the International Consortium of Universities for Drug Demand Reduction (ICUDDR) marked an important milestone with the global launch of the Universal Nurses Addiction Curriculum (UNAC). This initiative, supported by the U...
INTRODUCTION: Third-party sperm donation represents the sole viable option for conception for a considerable number of infertile couples. The donation process is predicated on ensuring the high quality and safety of the donated cells. While...
10 щорічна конференція Асоціації психіатрів України з міжнародною участю «Можливості у сфері психічного здоров’я в країні, що перебуває у стані війни» відбулася у Києві 10-11 жовтня 2024 р. у гібридному форматі (офлайн і онлайн).
В...
A significant number of individuals with alcohol use disorder (AUD) do not seek treatment, and the factors influencing treatment-seeking behavior are not well understood. While it is known that alcohol consumption levels can fluctuate with...
